C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
167/103, 167/129
C12N 15/62 (2006.01) A61K 39/395 (2006.01) C07K 16/30 (2006.01) C07K 16/46 (2006.01) C12N 15/13 (2006.01) A61K 38/00 (2006.01)
Patent
CA 2019559
The invention relates to bispecific and oligospecific, mono- and oligovalent receptors which are prepared by gene manipulation by fusion of DNA coding for F(ab) fragments of antibodies of two or more different specificities by means of suitable linkers. In this connection, one specificity is preferably directed either against an epitope, which is located on the cell membrane or in the interstitium, of a tumor-associated antigen (TAA) or against an epitope in the tumor endothelium (TE), while the other specificities relate to highmolecular or low- molecular weight ligands and react, for example, with the Komplexons ethylenediaminetetraacetate and diethylenetriaminepentaacetate in Y90 complexed-form (EDTA-Y90 and DTPA-Y90 respectively). In a particularly preferred embodiment, the binding with the Komplexons takes place on the Komplexon receptor arm via fos-jun interaction (or else avidin-biotin interaction). Other preferred specificities have catalytic properties.
Bosslet Klaus
Hermentin Peter
Kuhlmann Ludwig
Seemann Gerhard
Steinstraßer Axel
Behringwerke Aktiengesellschaft
Bereskin & Parr Llp/s.e.n.c.r.l.,s.r.l.
LandOfFree
Bispecific and oligospecific mono- and oligovalent... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Bispecific and oligospecific mono- and oligovalent..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Bispecific and oligospecific mono- and oligovalent... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1767892